glp 3 is retatrutide GLP-3 RT (LY3437943) Peptide Lux Medical OC | Services
Description
Tirzepatide outperforms all previous GLP-1 single agonists (including semaglutide)
Frequency depends on the person a study in the Scandinavian Journal of Gastroenterology found that regular bowel movements could range from three times per week to three times per day
2023;18:e0295451
Urbina et al
[DOI] [PubMed] [Google Scholar] 72.Liu L., et al
All three share similar gastrointestinal side effect profiles: nausea, diarrhea, constipation, and abdominal discomfort
